A Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-cell or Follicular Non-Hodgkin's Lymphoma (RATE)
Clinical trial NCT00719472 · COMPLETED
Trial details
- NCT number
- NCT00719472
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2011-05-01
- Enrollment
- 451
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.